Natural Mucosal Barriers and COVID-19 in Children

Abstract COVID-19 is more benign in children compared to adults for unknown reasons. This contrasts with other respiratory viruses where disease manifestations are often more severe in children. We hypothesized that a more robust early innate immune response to SARS-CoV-2 may protect against severe disease and compared clinical outcomes, viral copies and cellular gene and protein expression in nasopharyngeal swabs from 12 children and 27 adults upon presentation to the Emergency Department. SARS-CoV-2 copies were similar, but compared to adults, children displayed higher expression of genes associated with interferon signaling, NLRP3 inflammasome, and other innate pathways. Higher levels of IFN-α2, IFN-γ, IP-10, IL-8, and IL-1β protein were detected in nasal fluid in children versus adults. Anti-SARS-CoV-2 IgA and IgG were detected in nasal fluid from both groups and correlated negatively with mucosal IL-18. These findings suggest that a vigorous mucosal immune response in children compared to adults contributes to favorable clinical outcomes..

Medienart:

Preprint

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

bioRxiv.org - (2021) vom: 18. Feb. Zur Gesamtaufnahme - year:2021

Sprache:

Englisch

Beteiligte Personen:

Pierce, Carl A. [VerfasserIn]
Sy, Sharlene [VerfasserIn]
Galen, Benjamin [VerfasserIn]
Goldstein, Doctor Y [VerfasserIn]
Orner, Erika [VerfasserIn]
Keller, Marla J. [VerfasserIn]
Herold, Kevan C. [VerfasserIn]
Herold, Betsy C. [VerfasserIn]

Links:

Volltext [kostenfrei]

doi:

10.1101/2021.02.12.21251310

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

XBI019935250